Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study
2024 · Clinical and Molecular Hepatology · 27 citations
https://doi.org/10.3350/cmh.2024.0145
M
Meng Sha
Sinopec (China)(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
151
Papers
4.3K
Citations
22
h-index
40
i10-index
Meng Sha is an academic researcher from Sinopec (China). The author has contributed to research in topics: Cholangiocarcinoma and Gallbladder Cancer Studies & Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment. The author has an h-index of 22, co-authored 129 publications.
ORCID: 0000-0003-4492-1189Papers by this author
worksTumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
2019 · BMC Cancer · 26 citations
https://doi.org/10.1186/s12885-019-5420-z
A gene signature is critical for intrahepatic cholangiocarcinoma stem cell self-renewal and chemotherapeutic response
2022 · Stem Cell Research & Therapy · 14 citations
https://doi.org/10.1186/s13287-022-02988-9
Single-cell analyses reveal metastasis mechanism and microenvironment remodeling of lymph node in intrahepatic cholangiocarcinoma
2024 · JHEP Reports · 5 citations
https://doi.org/10.1016/j.jhepr.2024.101275
Semi-rational design of an aromatic dioxygenase by substrate tunnel redirection
2024 · iScience · 2 citations
https://doi.org/10.1016/j.isci.2024.111570
Severe metabolic accumulation of VV116 in kidney transplant patients with impaired renal function: a case series report
2025 · Frontiers in Immunology · 2 citations
https://doi.org/10.3389/fimmu.2024.1501813
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat